Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression

References

• Bonen A, Campbell SE, Benton CR, et al. (2004). Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc, 63:245–9
   PubMed Web of Science ®Google Scholar
• Chang HJ, Park JS, Kim MH, et al. (2006). Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells. Int J Oncol, 28:135–41
   PubMed Web of Science ®Google Scholar
• Chen M, Pych E, Corpron C, Harmon CM. (2002). Regulation of CD36 expression in human melanoma cells. Adv Exp Med Biol, 507:337–42
   PubMed Web of Science ®Google Scholar
• Dietze-Schroeder D, Sell H, Uhlig M, et al. (2005). Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes, 54:2003–11
   PubMed Web of Science ®Google Scholar
• Famulla S, Lamers D, Hartwig S, et al. (2010). Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes (Lond), 35:762–72
   PubMed Web of Science ®Google Scholar
• Febbraio M, Silverstein RL. (2007). CD36: implications in cardiovascular disease. Int J Biochem Cell Biol, 39:2012–30
   PubMed Web of Science ®Google Scholar
• Hauner H, Petruschke T, Russ M, et al. (1995). Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia, 38:764–71
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. (2006). Inflammation and metabolic disorders. Nature, 444:860–67
   PubMed Web of Science ®Google Scholar
• Hu FB, Willett WC, Li T, et al. (2004). Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med, 351:2694–703
   PubMed Web of Science ®Google Scholar
• Iacobellis G, SHARMA AM. (2007). Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des, 13:2180–84
   PubMed Web of Science ®Google Scholar
• Kazerounian S, Duquette M, Reyes MA, et al. (2011). Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase. Blood, 117:4658–66
   PubMed Web of Science ®Google Scholar
• Koonen DP, Febbraio M, Bonnet S, et al. (2007). CD36 expression contributes to age-induced cardiomyopathy in mice. Circulation, 116:2139–47
   PubMed Web of Science ®Google Scholar
• Kuchibhotla S, Vanegas D, Kennedy DJ, et al. (2008). Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc Res, 78:185–96
   Google Scholar
• Lamers D, Schlich R, Greulich S, et al. (2011). Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J Cell Mol Med, 15:1177–88
   Google Scholar
• Lamers D, Schlich R, Horrighs A, et al. (2012). Differential impact of oleate, palmitate, and adipokines on expression of NF-kappaB target genes in human vascular smooth muscle cells. Mol Cell Endocrinol, 362:194–201
   PubMed Web of Science ®Google Scholar
• Ma S, Yang D, Li D, et al. (2011). Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36. Lipids Health Dis, 10:53
   PubMed Web of Science ®Google Scholar
• Mathieu P, Lemieux I, Despres JP. (2010). Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther, 87:407–16
   PubMed Web of Science ®Google Scholar
• Nagy L, Tontonoz P, Alvarez JG, et al. (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell, 93:229–40
   PubMed Web of Science ®Google Scholar
• Nicholson AC. (2004). Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. Trends Cardiovasc Med, 14:8–12
   PubMed Web of Science ®Google Scholar
• Page K, Hershenson MB. (2000). Mitogen-activated signaling and cell cycle regulation in airway smooth muscle. Front Biosci, 5:D258–67
   PubMed Web of Science ®Google Scholar
• Ruan H, Lodish HF. (2003). Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev, 14:447–55
   PubMed Web of Science ®Google Scholar
• Schlich R, Willems M, Greulich S, et al. (2013). VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue. Mediators Inflamm, 2013:982458
   PubMed Web of Science ®Google Scholar
• Sell H, Dietze-Schroeder D, Kaiser U, Eckel J. (2006). Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology, 147:2458–67
   PubMed Web of Science ®Google Scholar
• Sell H, Eckardt K, Taube A, et al. (2008). Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility. Am J Physiol Endocrinol Metab, 294:E1070–77
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine, AB. (2006). Inflammation and insulin resistance. J Clin Invest, 116:1793–801
   PubMed Web of Science ®Google Scholar
• Sima AV, Botez GM, Stancu CS, et al. (2010). Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. J Cell Mol Med, 14:2790–802
   PubMed Web of Science ®Google Scholar
• Streit M, Velasco P, Brown LF, et al. (1999). Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol, 155:441–52
   PubMed Web of Science ®Google Scholar
• Taube A, Lambernd S, van Echten-Deckert G, et al. (2012a). Adipokines promote lipotoxicity in human skeletal muscle cells. Arch Physiol Biochem, 118:92–101
   PubMed Web of Science ®Google Scholar
• Taube A, Schlich R, Sell H, et al. (2012b). Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol, 302:H2148–65
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Nagy L, Alvarez JG, et al. (1998). PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93:241–52
   PubMed Web of Science ®Google Scholar
• van Dam RM, Willett WC, Manson JE, Hu FB. (2006). The relationship between overweight in adolescence and premature death in women. Ann Intern Med, 145:91–7
   PubMed Web of Science ®Google Scholar
• Wichelhaus A, Russ M, Petersen S, Eckel J. (1994). G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am J Physiol, 267:H548–55
   PubMed Web of Science ®Google Scholar
• Wronkowitz N, Gorgens SW, Romacho T, et al. (2014). Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2. Biochim Biophys Acta, 1842:1613–21
   PubMed Web of Science ®Google Scholar
• Xue JH, Yuan Z, Wu Y, et al. (2010). High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res, 86:141–50
   PubMed Web of Science ®Google Scholar
• Yesner LM, Huh HY, Pearce SF, Silverstein RL. (1996). Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol, 16:1019–25
   PubMed Web of Science ®Google Scholar
• Zhang X, Kazerounian S, Duquette M, et al. (2009). Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J, 23:3368–76
   PubMed Web of Science ®Google Scholar